Why can a test with high specificity still yield many false positives?

Why can a test with high specificity still yield many false positives?

• A. Operator error
• B. Low disease prevalence
• C. High disease prevalence
• D. Sample contamination

Answer: (B)

When assessing why a test with high specificity can still produce many false positives, focus on the role of prevalence in screening outcomes. Specificity measures how well the test avoids labeling non-diseased individuals as positive, so the false positive rate is low. But if the disease is rare, most people tested do not have the disease, creating a very large group of non-diseased individuals. Even a small false positive rate applied to that large group can yield a substantial number of false positives in total. This is why, in settings with low disease prevalence, there can be many positive results that are actually false, and the positive predictive value of the test declines. Extrinsic issues like operator error or sample contamination could affect results, but they don't explain the scenario where high specificity still leads to many false positives in a low-prevalence population. Conversely, high disease prevalence would reduce the pool of non-diseased and thus the absolute number of false positives would be lower.

When assessing why a test with high specificity can still produce many false positives, focus on the role of prevalence in screening outcomes. Specificity measures how well the test avoids labeling non-diseased individuals as positive, so the false positive rate is low. But if the disease is rare, most people tested do not have the disease, creating a very large group of non-diseased individuals. Even a small false positive rate applied to that large group can yield a substantial number of false positives in total. This is why, in settings with low disease prevalence, there can be many positive results that are actually false, and the positive predictive value of the test declines.

Extrinsic issues like operator error or sample contamination could affect results, but they don't explain the scenario where high specificity still leads to many false positives in a low-prevalence population. Conversely, high disease prevalence would reduce the pool of non-diseased and thus the absolute number of false positives would be lower.